Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
Articolo
Data di Pubblicazione:
2017
Citazione:
Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker? / De Marchi, F.; Candoni, A.; Zannier, M. E.; Haley, L.; Lau, B. W. Y.; Fanin, R.. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 92:5(2017), pp. E72-E74. [10.1002/ajh.24686]
Tipologia CRIS:
Articolo su rivista
Elenco autori:
De Marchi, F.; Candoni, A.; Zannier, M. E.; Haley, L.; Lau, B. W. Y.; Fanin, R.
Link alla scheda completa:
Link al Full Text:
Pubblicato in: